Iheozor-Ejiofor Zipporah, Middleton Philippa, Esposito Marco, Glenny Anne-Marie
Division of Nursing, Midwifery and Social Work, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Jean McFarlane Building, Oxford Road, Manchester, UK, M13 9PL.
Cochrane Database Syst Rev. 2017 Jun 12;6(6):CD005297. doi: 10.1002/14651858.CD005297.pub3.
Periodontal disease has been linked with a number of conditions, such as cardiovascular disease, stroke, diabetes and adverse pregnancy outcomes, all likely through systemic inflammatory pathways. It is common in women of reproductive age and gum conditions tend to worsen during pregnancy. Some evidence from observational studies suggests that periodontal intervention may reduce adverse pregnancy outcomes. There is need for a comprehensive Cochrane review of randomised trials to assess the effect of periodontal treatment on perinatal and maternal health.
To assess the effects of treating periodontal disease in pregnant women in order to prevent or reduce perinatal and maternal morbidity and mortality.
Cochrane Oral Health's Information Specialist searched the following databases: Cochrane Oral Health's Trials Register (to 6 October 2016), Cochrane Pregnancy and Childbirth's Trials Register (to 7 October 2016), the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 9) in the Cochrane Library, MEDLINE Ovid (1946 to 6 October 2016), Embase Ovid (1980 to 6 October 2016), and LILACS BIREME Virtual Health Library (Latin American and Caribbean Health Science Information database; 1982 to 6 October 2016). ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform were searched for ongoing trials on 6 October 2016. We placed no restrictions on the language or date of publication when searching the electronic databases.
We included all randomised controlled trials (RCTs) investigating the effects of periodontal treatment in preventing or reducing perinatal and maternal morbidity and mortality. We excluded studies where obstetric outcomes were not reported.
Two review authors independently screened titles and abstracts and extracted data using a prepiloted data extraction form. Missing data were obtained by contacting authors and risk of bias was assessed using Cochrane's 'Risk of bias' tool. Where appropriate, results of comparable trials were pooled and expressed as risk ratios (RR) or mean differences (MD) with 95% confidence intervals (CI) . The random-effects model was used for pooling except where there was an insufficient number of studies. We assessed the quality of the evidence using GRADE.
There were 15 RCTs (n = 7161 participants) meeting our inclusion criteria. All the included studies were at high risk of bias mostly due to lack of blinding and imbalance in baseline characteristics of participants. The studies recruited pregnant women from prenatal care facilities who had periodontitis (14 studies) or gingivitis (1 study).The two main comparisons were: periodontal treatment versus no treatment during pregnancy and periodontal treatment versus alternative periodontal treatment. The head-to-head comparison between periodontal treatments assessed a more intensive treatment versus a less intensive one.Eleven studies compared periodontal treatment with no treatment during pregnancy. The meta-analysis shows no clear difference in preterm birth < 37 weeks (RR 0.87, 95% CI 0.70 to 1.10; 5671 participants; 11 studies; low-quality evidence) between periodontal treatment and no treatment. There is low-quality evidence that periodontal treatment may reduce low birth weight < 2500 g (9.70% with periodontal treatment versus 12.60% without treatment; RR 0.67, 95% CI 0.48 to 0.95; 3470 participants; 7 studies).It is unclear whether periodontal treatment leads to a difference in preterm birth < 35 weeks (RR 1.19, 95% CI 0.81 to 1.76; 2557 participants; 2 studies; ) and < 32 weeks (RR 1.35, 95% CI 0.78 to 2.32; 2755 participants; 3 studies), low birth weight < 1500 g (RR 0.80, 95% CI 0.38 to 1.70; 2550 participants; 2 studies), perinatal mortality (including fetal and neonatal deaths up to the first 28 days after birth) (RR 0.85, 95% CI 0.51 to 1.43; 5320 participants; 7 studies; very low-quality evidence), and pre-eclampsia (RR 1.10, 95% CI 0.74 to 1.62; 2946 participants; 3 studies; very low-quality evidence). There is no evidence of a difference in small for gestational age (RR 0.97, 95% CI 0.81 to 1.16; 3610 participants; 3 studies; low-quality evidence) when periodontal treatment is compared with no treatment.Four studies compared periodontal treatment with alternative periodontal treatment. Data pooling was not possible due to clinical heterogeneity. The outcomes reported were preterm birth < 37 weeks, preterm birth < 35 weeks, birth weight < 2500 g, birth weight < 1500 g and perinatal mortality (very low-quality evidence). It is unclear whether there is a difference in < 37 weeks, preterm birth < 35 weeks, birth weight < 2500 g, birth weight < 1500 g and perinatal mortality when different periodontal treatments are compared because the quality of evidence is very low.Maternal mortality and adverse effects of the intervention did not occur in any of the studies that reported on either of the outcomes.
AUTHORS' CONCLUSIONS: It is not clear if periodontal treatment during pregnancy has an impact on preterm birth (low-quality evidence). There is low-quality evidence that periodontal treatment may reduce low birth weight (< 2500 g), however, our confidence in the effect estimate is limited. There is insufficient evidence to determine which periodontal treatment is better in preventing adverse obstetric outcomes. Future research should aim to report periodontal outcomes alongside obstetric outcomes.
牙周疾病与多种病症相关,如心血管疾病、中风、糖尿病及不良妊娠结局等,所有这些可能都通过全身炎症途径产生关联。牙周疾病在育龄女性中很常见,且牙龈状况在孕期往往会恶化。一些观察性研究的证据表明,牙周干预可能会减少不良妊娠结局。因此需要通过Cochrane系统评价对随机试验进行全面评估,以确定牙周治疗对围产期和孕产妇健康的影响。
评估治疗孕妇牙周疾病对预防或降低围产期及孕产妇发病率和死亡率的效果。
Cochrane口腔健康信息专家检索了以下数据库:Cochrane口腔健康试验注册库(截至2016年10月6日)、Cochrane妊娠与分娩试验注册库(截至2016年10月7日)、Cochrane图书馆中的Cochrane对照试验中央注册库(CENTRAL;2016年第9期)、MEDLINE Ovid(1946年至2016年10月6日)、Embase Ovid(1980年至2016年10月6日)以及LILACS BIREME虚拟健康图书馆(拉丁美洲和加勒比健康科学信息数据库;1982年至2016年10月6日)。2016年10月6日,检索了ClinicalTrials.gov和世界卫生组织国际临床试验注册平台以查找正在进行的试验。检索电子数据库时,我们未对语言或出版日期设限。
我们纳入了所有研究牙周治疗对预防或降低围产期及孕产妇发病率和死亡率影响的随机对照试验(RCT)。我们排除了未报告产科结局的研究。
两位综述作者独立筛选标题和摘要,并使用预先设计的数据提取表提取数据。通过与作者联系获取缺失数据,并使用Cochrane的“偏倚风险”工具评估偏倚风险。在适当情况下,对可比试验的结果进行合并,并以风险比(RR)或均值差(MD)及95%置信区间(CI)表示。除研究数量不足外,均采用随机效应模型进行合并。我们使用GRADE评估证据质量。
有15项RCT(n = 7161名参与者)符合我们的纳入标准。所有纳入研究大多因缺乏盲法和参与者基线特征不均衡而存在高偏倚风险。这些研究招募了来自产前保健机构的患有牙周炎(14项研究)或牙龈炎(1项研究)的孕妇。两项主要比较为:孕期牙周治疗与未治疗,以及牙周治疗与替代牙周治疗。牙周治疗之间的直接比较评估了强化治疗与非强化治疗。11项研究比较了孕期牙周治疗与未治疗。荟萃分析显示,在孕周<37周的早产方面,牙周治疗与未治疗之间无明显差异(RR = 0.87,95%CI 0.70至1.10;5671名参与者;11项研究;低质量证据)。有低质量证据表明,牙周治疗可能会降低出生体重<2500g的发生率(牙周治疗组为9.70%,未治疗组为12.60%;RR = 0.67,95%CI 0.48至0.95;3470名参与者;7项研究)。目前尚不清楚牙周治疗是否会导致孕周<35周(RR = 1.19,95%CI 0.81至1.76;2557名参与者;2项研究)和<32周(RR = 1.35, 95%CI 0.78至2.32;2755名参与者;3项研究)的早产、出生体重<1500g(RR = 0.80,95%CI 0.38至1.70;2550名参与者;2项研究)、围产期死亡率(包括出生后前28天内的胎儿和新生儿死亡)(RR = 0.85,95%CI 0.51至1.43;5320名参与者;7项研究;极低质量证据)以及子痫前期(RR = 1.10,95%CI 0.74至1.62;2946名参与者;3项研究;极低质量证据)出现差异。在与未治疗相比时,没有证据表明牙周治疗在小于胎龄儿方面存在差异(RR = 0.97,95%CI 0.81至1.16;3610名参与者;3项研究;低质量证据)。4项研究比较了牙周治疗与替代牙周治疗。由于临床异质性,无法进行数据合并。报告的结局为孕周<37周的早产、孕周<35周的早产、出生体重<2500g、出生体重<1500g和围产期死亡率(极低质量证据)。由于证据质量极低,尚不清楚比较不同牙周治疗时,在孕周<37周的早产、孕周<35周的早产、出生体重<2500g、出生体重<1500g和围产期死亡率方面是否存在差异。在报告了这两个结局中任何一个的研究中,均未发生孕产妇死亡和干预的不良反应。
尚不清楚孕期进行牙周治疗是否会对早产产生影响(低质量证据)。有低质量证据表明,牙周治疗可能会降低低出生体重(<2500g),然而,我们对效应估计值的信心有限。没有足够的证据来确定哪种牙周治疗在预防不良产科结局方面更好。未来的研究应旨在同时报告牙周结局和产科结局。